{
  "pmid": "23718309",
  "uid": "23718309",
  "title": "Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.",
  "abstract": "AIM: This study aimed to identify predictive/prognostic factors in castration-resistant prostate cancer patients treated with cabazitaxel. PATIENTS & METHODS: Patients were enrolled from March 2011 to December 2011 in an international expanded access program. In January 2012, when cabazitaxel became commercially available, a prospective study was initiated at University Federico II of Naples and at Rionero in Vulture Hospital. RESULTS: Forty-seven patients were enrolled in this study. Patients received a median of nine cycles of cabazitaxel. Median progression-free survival was 7.0 months (95% CI: 5.7-8.0). Seventeen patients were still alive at the time of the analysis, with a median overall survival of 14 months (95% CI: 11-16). At multivariate analysis, a higher Gleason score (≥ 8) appeared to be associated with prolonged progression-free survival (hazard ratio: 0.36; 95% CI: 0.18-0.72); however, the higher Gleason score showed no statistical impact on overall survival. CONCLUSION: We hypothesize that the Gleason score has the potential to be incorporated in the clinical decision-making process for definition of treatment strategy in docetaxel-pretreated castration-resistant prostate cancer patients. We encourage further experimentation in this setting.",
  "authors": [
    {
      "last_name": "Buonerba",
      "fore_name": "Carlo",
      "initials": "C",
      "name": "Carlo Buonerba",
      "affiliations": [
        "Genitourinary Cancer Section, Medical Oncology Division, Department of Endocrinology & Oncology, University Federico II, Napoli, Italy."
      ]
    },
    {
      "last_name": "Pond",
      "fore_name": "Gregory R",
      "initials": "GR",
      "name": "Gregory R Pond",
      "affiliations": []
    },
    {
      "last_name": "Sonpavde",
      "fore_name": "Guru",
      "initials": "G",
      "name": "Guru Sonpavde",
      "affiliations": []
    },
    {
      "last_name": "Federico",
      "fore_name": "Piera",
      "initials": "P",
      "name": "Piera Federico",
      "affiliations": []
    },
    {
      "last_name": "Rescigno",
      "fore_name": "Pasquale",
      "initials": "P",
      "name": "Pasquale Rescigno",
      "affiliations": []
    },
    {
      "last_name": "Puglia",
      "fore_name": "Livio",
      "initials": "L",
      "name": "Livio Puglia",
      "affiliations": []
    },
    {
      "last_name": "Bosso",
      "fore_name": "Davide",
      "initials": "D",
      "name": "Davide Bosso",
      "affiliations": []
    },
    {
      "last_name": "Virtuoso",
      "fore_name": "Antonella",
      "initials": "A",
      "name": "Antonella Virtuoso",
      "affiliations": []
    },
    {
      "last_name": "Policastro",
      "fore_name": "Tania",
      "initials": "T",
      "name": "Tania Policastro",
      "affiliations": []
    },
    {
      "last_name": "Izzo",
      "fore_name": "Michela",
      "initials": "M",
      "name": "Michela Izzo",
      "affiliations": []
    },
    {
      "last_name": "Vaccaro",
      "fore_name": "Luca",
      "initials": "L",
      "name": "Luca Vaccaro",
      "affiliations": []
    },
    {
      "last_name": "Ferro",
      "fore_name": "Matteo",
      "initials": "M",
      "name": "Matteo Ferro",
      "affiliations": []
    },
    {
      "last_name": "Aieta",
      "fore_name": "Michele",
      "initials": "M",
      "name": "Michele Aieta",
      "affiliations": []
    },
    {
      "last_name": "Perdonà",
      "fore_name": "Sisto",
      "initials": "S",
      "name": "Sisto Perdonà",
      "affiliations": []
    },
    {
      "last_name": "Palmieri",
      "fore_name": "Giovannella",
      "initials": "G",
      "name": "Giovannella Palmieri",
      "affiliations": []
    },
    {
      "last_name": "De Placido",
      "fore_name": "Sabino",
      "initials": "S",
      "name": "Sabino De Placido",
      "affiliations": []
    },
    {
      "last_name": "Di Lorenzo",
      "fore_name": "Giuseppe",
      "initials": "G",
      "name": "Giuseppe Di Lorenzo",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Future oncology (London, England)",
    "iso_abbreviation": "Future Oncol",
    "issn": "1744-8301",
    "issn_type": "Electronic",
    "volume": "9",
    "issue": "6",
    "pub_year": "2013",
    "pub_month": "Jun"
  },
  "start_page": "889",
  "end_page": "897",
  "pages": "889-97",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Aged",
    "Castration",
    "Disease-Free Survival",
    "Humans",
    "Male",
    "Middle Aged",
    "Neoplasm Grading",
    "Neoplasm Metastasis",
    "Neoplasm Staging",
    "Prognosis",
    "Prospective Studies",
    "Prostate-Specific Antigen",
    "Prostatic Neoplasms",
    "Taxoids"
  ],
  "article_ids": {
    "pubmed": "23718309",
    "doi": "10.2217/fon.13.39"
  },
  "doi": "10.2217/fon.13.39",
  "dates": {
    "completed": "2013-11-01",
    "revised": "2022-03-17"
  },
  "chemicals": [
    "Taxoids",
    "cabazitaxel",
    "Prostate-Specific Antigen"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:52:44.867649",
    "pmid": "23718309"
  }
}